MedTrace Logo

Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being

NCT00988910 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 632

Last updated 2014-06-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the symptoms and satisfaction for women taking drospirenone (DRSP)-containing combined oral contraceptives in comparison with women taking other kind of combined oral contraceptives.

Conditions

  • Contraception

Interventions

DRUG

EE30-DRSP (Yasmin, BAY86-5131)

DRSP-containing combined oral contraceptives according to the normal routine praxis

DRUG

Other combined oral contraceptives

Other combined oral contraceptives according to the normal routine praxis

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-12-31
Completion
2010-12-31

Countries

  • Italy

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00988910 on ClinicalTrials.gov